6.
Morisseau C, Hammock B
. Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health. Annu Rev Pharmacol Toxicol. 2012; 53:37-58.
PMC: 3578707.
DOI: 10.1146/annurev-pharmtox-011112-140244.
View
7.
Song Y, Zhang Q, Li Y, Yan R, Wang Y
. Enantioseparation and absolute configuration determination of angular-type pyranocoumarins from peucedani radix using enzymatic hydrolysis and chiral HPLC-MS/MS analysis. Molecules. 2012; 17(4):4236-51.
PMC: 6268167.
DOI: 10.3390/molecules17044236.
View
8.
Spector A, Fang X, Snyder G, Weintraub N
. Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function. Prog Lipid Res. 2003; 43(1):55-90.
DOI: 10.1016/s0163-7827(03)00049-3.
View
9.
Imig J, Hammock B
. Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases. Nat Rev Drug Discov. 2009; 8(10):794-805.
PMC: 3021468.
DOI: 10.1038/nrd2875.
View
10.
Kim H, Moon S, Lee S, Hwang G, Yoo H, Song J
. The arachidonic acid metabolite 11,12-epoxyeicosatrienoic acid alleviates pulmonary fibrosis. Exp Mol Med. 2021; 53(5):864-874.
PMC: 8178404.
DOI: 10.1038/s12276-021-00618-7.
View
11.
Hisamoto M, Kikuzaki H, Ohigashi H, Nakatani N
. Antioxidant compounds from the leaves of Peucedanum japonicum thunb. J Agric Food Chem. 2003; 51(18):5255-61.
DOI: 10.1021/jf0262458.
View
12.
Spector A, Norris A
. Action of epoxyeicosatrienoic acids on cellular function. Am J Physiol Cell Physiol. 2006; 292(3):C996-1012.
DOI: 10.1152/ajpcell.00402.2006.
View
13.
Wolf N, Morisseau C, Jones P, Hock B, Hammock B
. Development of a high-throughput screen for soluble epoxide hydrolase inhibition. Anal Biochem. 2006; 355(1):71-80.
PMC: 1964503.
DOI: 10.1016/j.ab.2006.04.045.
View
14.
Arand M, Wagner H, Oesch F
. Asp333, Asp495, and His523 form the catalytic triad of rat soluble epoxide hydrolase. J Biol Chem. 1996; 271(8):4223-9.
DOI: 10.1074/jbc.271.8.4223.
View
15.
Jang D, Park E, Hawthorne M, Vigo J, Graham J, Cabieses F
. Potential cancer chemopreventive constituents of the seeds of Dipteryx odorata (tonka bean). J Nat Prod. 2003; 66(5):583-7.
DOI: 10.1021/np020522n.
View
16.
Wang B, Wu L, Chen J, Dong L, Chen C, Wen Z
. Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets. Signal Transduct Target Ther. 2021; 6(1):94.
PMC: 7910446.
DOI: 10.1038/s41392-020-00443-w.
View
17.
Tao W, Li P, Yang L, Ma Y
. Effects of a Soluble Epoxide Hydrolase Inhibitor on Lipopolysaccharide-Induced Acute Lung Injury in Mice. PLoS One. 2016; 11(8):e0160359.
PMC: 4973880.
DOI: 10.1371/journal.pone.0160359.
View
18.
Kim J, Imig J, Yang J, Hammock B, Padanilam B
. Inhibition of soluble epoxide hydrolase prevents renal interstitial fibrosis and inflammation. Am J Physiol Renal Physiol. 2014; 307(8):F971-80.
PMC: 4200297.
DOI: 10.1152/ajprenal.00256.2014.
View
19.
Zhang J, Yang F, Zhu Q, Zhang W, Zhang M, Yi J
. Inhibition effect of 1-acetoxy-6α-(2-methylbutyryl)eriolanolide toward soluble epoxide hydrolase: Multispectral analysis, molecular dynamics simulation, biochemical, and in vitro cell-based studies. Int J Biol Macromol. 2023; 235:123911.
DOI: 10.1016/j.ijbiomac.2023.123911.
View
20.
Liu Z, Sun C, Xu J, Morisseau C, Hammock B, Qiu F
. Phytochemical constituents from Scutellaria baicalensis in soluble epoxide hydrolase inhibition: Kinetics and interaction mechanism merged with simulations. Int J Biol Macromol. 2019; 133:1187-1193.
DOI: 10.1016/j.ijbiomac.2019.04.055.
View